Table 1.

Comparison of cemented and uncemented hip arthroplasty for pathologic disease of the proximal femur.

	Cemented	Uncemented	P value
Age (years)	Range: 51-91 Mean: 70	Range: 34-85 Mean: 67	0.39
BMI	Range: 17-37 Mean: 25	Range: 16-39 Mean: 27	0.17
Cancer Diagnosis
Prostate	3 (16.7%)	7 (30.4%)
Lung	4 (22.2%)	4 (17.4%)
Breast	4 (22.2%)	2 (8.7%)
Renal Cell	2 (11.1%)	2 (8.7%)
Primary bone or soft tissue tumor	3 (16.7%)	3 (13.0%)
Other *	2 (11.1%)	5 (21.7%)
Chemotherapy	11 (61%)	20 (86%)	0.06
Neoadjuvant Radiation (n=7)	4 (22%)	3 (13%)	0.44
Adjuvant Radiation (n=7)	2 (11%)	5 (22%)	0.37
Osteogenic Agents (n=6)	2 (11%)	4 (17%)	0.57
Implants	18	23
Hemiarthroplasty	8 (44%)	16 (70%)
Diaphyseal grit blasted	–	13 (81%)
Metaphyseal coated	–	3 (9%)
Total Hip Arthroplasty	3 (17%)	0 (0%)
Proximal Femur Replacement (fully porous)	7 (39%)	7 (30%)
Average Intraoperative Blood loss (mL)	557	502	0.84
Average Intraoperative Transfusion Requirements (units)	0.75	0.83	0.98
Deceased	9 (50%)	10 (43.5%)	0.68
Age of implant at patient death (days)	Range: 11-345 Mean: 127	Range: 2-1401 Mean: 302	0.12
Complications
Total	16.7%	21.7%	0.53
30-day mortality	5.6%	8.7%	0.65
Pulmonary complications	5.6%	4.3%	0.77
Musculoskeletal Tumor Society Score (MSTS)	Range: 10-25 Mean: 17.9	Range: 10-30 Mean: 19.6	0.63
Harris Hip Score (HHS)	Range: 37-83 Mean: 58.7	Range: 32-87 Mean: 61.9	0.72